RAPIZZI, ELENA
 Distribuzione geografica
Continente #
NA - Nord America 5.964
EU - Europa 3.507
AS - Asia 2.977
SA - Sud America 417
Continente sconosciuto - Info sul continente non disponibili 132
AF - Africa 78
OC - Oceania 39
Totale 13.114
Nazione #
US - Stati Uniti d'America 5.855
RU - Federazione Russa 1.253
SG - Singapore 870
IT - Italia 866
CN - Cina 716
HK - Hong Kong 506
PL - Polonia 367
BR - Brasile 329
VN - Vietnam 290
KR - Corea 254
IE - Irlanda 243
SE - Svezia 224
FI - Finlandia 116
FR - Francia 114
DE - Germania 98
GB - Regno Unito 77
IN - India 75
BD - Bangladesh 64
CA - Canada 62
JO - Giordania 47
AR - Argentina 40
AU - Australia 39
UA - Ucraina 36
ID - Indonesia 33
NL - Olanda 32
CH - Svizzera 31
MX - Messico 23
IQ - Iraq 20
TR - Turchia 20
JP - Giappone 19
EC - Ecuador 17
BE - Belgio 15
ZA - Sudafrica 14
CI - Costa d'Avorio 13
MA - Marocco 11
PK - Pakistan 11
ES - Italia 10
LT - Lituania 8
NG - Nigeria 8
PY - Paraguay 8
PH - Filippine 7
CL - Cile 6
EG - Egitto 6
KE - Kenya 6
NP - Nepal 6
UZ - Uzbekistan 6
VE - Venezuela 6
BJ - Benin 5
CO - Colombia 5
AZ - Azerbaigian 4
NI - Nicaragua 4
RO - Romania 4
SA - Arabia Saudita 4
CR - Costa Rica 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
GA - Gabon 3
HN - Honduras 3
IL - Israele 3
KG - Kirghizistan 3
PE - Perù 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AT - Austria 2
BG - Bulgaria 2
BH - Bahrain 2
CZ - Repubblica Ceca 2
JM - Giamaica 2
MY - Malesia 2
PA - Panama 2
PS - Palestinian Territory 2
SN - Senegal 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BY - Bielorussia 1
ET - Etiopia 1
GT - Guatemala 1
HR - Croazia 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
MG - Madagascar 1
MV - Maldive 1
PR - Porto Rico 1
PT - Portogallo 1
RE - Reunion 1
RS - Serbia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 12.983
Città #
Santa Clara 1.057
Ashburn 829
Singapore 687
Fairfield 533
Hong Kong 455
Warsaw 364
Woodbridge 256
Seoul 251
Dublin 243
Chandler 225
San Jose 214
Cambridge 208
Seattle 196
Hefei 180
Wilmington 180
Houston 178
Beijing 166
Milan 165
Council Bluffs 115
Ann Arbor 108
Altamura 98
Lawrence 98
Florence 97
Los Angeles 85
Rome 81
Ho Chi Minh City 79
Buffalo 75
Lauterbourg 70
Moscow 69
Hanoi 67
Princeton 64
The Dalles 58
Jacksonville 54
New York 53
Helsinki 50
Munich 45
Boston 44
Mumbai 41
Boardman 36
Dallas 34
Melbourne 34
Medford 33
Kent 32
Paris 30
Shanghai 30
Jakarta 28
San Diego 28
Bern 25
Chicago 24
São Paulo 22
Bologna 19
Guangzhou 19
Naples 19
Haiphong 18
Orem 18
Tokyo 18
Turin 17
Brooklyn 16
Montreal 16
Figino 15
Lappeenranta 15
Redondo Beach 15
Brussels 14
Rio de Janeiro 14
Abidjan 13
Toronto 13
Venice 13
Chennai 12
Da Nang 12
London 12
Turku 12
West Jordan 12
Falls Church 11
Hillsboro 11
Dong Ket 10
Mexico City 10
Norwalk 10
Stanford 10
Yubileyny 10
Clifton 9
Curitiba 9
Frankfurt am Main 9
Guayaquil 9
Izmir 9
Salt Lake City 9
Abuja 8
Phoenix 8
Redmond 8
Redwood City 8
Ankara 7
Belo Horizonte 7
Bengaluru 7
Casablanca 7
Haarlem 7
Johannesburg 7
Palermo 7
Shenzhen 7
Verona 7
Amsterdam 6
Baghdad 6
Totale 8.759
Nome #
Cancer-associated fibroblasts promote prostate cancer malignancy via metabolic rewiring and mitochondrial transfer 298
DIAGNOSIS of ENDOCRINE DISEASE: SDHx mutations: Beyond pheochromocytomas and paragangliomas 297
Updated and new perspectives on diagnosis, prognosis, and therapy of malignant pheochromocytoma/paraganglioma. 291
INT-767 prevents NASH and promotes visceral fat brown adipogenesis and mitochondrial function 269
miR-210-3p mediates metabolic adaptation and sustains DNA damage repair of resistant colon cancer cells to treatment with 5-fluorouracil 249
A unique neuroendocrine cell model derived from the human foetal neural crest. 239
Genetic-clinical profile of subjects with apparently sporadic extra-adrenal paragangliomas. 234
Epigenetic Mutation of the Succinate Dehydrogenase C Promoter in a Patient With Two Paragangliomas. 229
Testosterone improves muscle fiber asset and exercise performance in a metabolic syndrome model. 222
15 YEARS OF PARAGANGLIOMA: Metabolism and pheochromocytoma/paraganglioma 220
Early derangement of axonal mitochondria occurs in a mouse model of progressive but not relapsing-remitting multiple sclerosis 218
The aggressiveness of succinate dehydrogenase subunit B-deficient chromaffin cells is reduced when their bioelectrical properties are restored by glibenclamide 204
Metformin Treatment Induces Different Response in Pheochromocytoma/Paraganglioma Tumour Cells and in Primary Fibroblasts 202
Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients 199
Poly(ADP-ribose) polymerase-1 is a nuclear epigenetic regulator of mitochondrial DNA repair and transcription 198
The role of PPAR-γ system in normal and tumoral corticotroph pituitary and adrenal cells. 195
ED2+ macrophages increase selectively myoblast proliferation in muscle cultures. 195
Hypogonadism and sexual function in men affected by adrenocortical carcinoma under mitotane therapy 187
Morphofunctional effects of mitotane on mitochondria in human adrenocortical cancer cells. 185
Sunitinib in the therapy of malignant paragangliomas: Report on the efficacy in a sdhb mutation carrier and review of the literature 184
[68Ga]DOTATOC PET-derived radiomics to predict genetic background of head and neck paragangliomas: a pilot investigation 183
A multicenter epidemiological study on second malignancy in non-syndromic pheochromocytoma/paraganglioma patients in Italy 183
Co-occurrence of mutations in NF1 and other susceptibility genes in pheochromocytoma and paraganglioma 181
Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma 179
Yeast model for evaluating the pathogenic significance of SDHB, SDHC and SDHD mutations in PHEO-PGL syndrome. 175
Hemodynamic parameters in patients undergoing surgery for pheochromocytoma/paraganglioma: a retrospective study 174
Mitochondrial function and content in Pheochromocytoma/paraganglioma of succinate dehydrogenase mutation carriers 174
Testosterone treatment is associated with reduced adipose tissue dysfunction and nonalcoholic fatty liver disease in obese hypogonadal men 174
MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma 171
Role of microenvironment on neuroblastoma SK-N-AS SDHB-silenced cell metabolism and function 171
The microenvironment induces collective migration in SDHB-silenced mouse pheochromocytoma spheroids 169
Novel Germline PHD2 Variant in a Metastatic Pheochromocytoma and Chronic Myeloid Leukemia, but in the Absence of Polycythemia 169
Germline Mutation in KIF1Bβ Gene Associated with Loss of Heterozygosity: Usefulness of Next-Generation Sequencing in the Genetic Screening of Patients with Pheochromocytoma 168
The 3D in vitro Adrenoid cell model recapitulates the complexity of the adrenal gland 166
Clinical relevance of phenotype/genotype correlations in the diagnosis and therapy of pheochromocytomas/paragangliomas. 165
SDHB and SDHD silenced pheochromocytoma spheroids respond differently to tumour microenvironment and their aggressiveness is inhibited by impairing stroma metabolism 165
The regulatory effect of sex steroids on the RhoA/ROCK pathway in the rat distal vagina 164
Succinate dehydrogenase subunit B mutations modify human neuroblastoma cell metabolism and proliferation 163
Functional significance of germline EPAS1 variants 163
Tumour microenvironment in pheochromocytoma and paraganglioma 161
Correction for age of anticardiolipin antibodies cut-off points. 160
Antiphospholipid antibody syndrome and polymyalgia rheumatica/giant cell arteritis. 159
Metabolome-guided genomics to identify pathogenic variants in isocitrate dehydrogenase, fumarate hydratase, and succinate dehydrogenase genes in pheochromocytoma and paraganglioma 159
Inhibition of nicotinamide phosphoribosyltransferase: cellular bioenergetics reveals a mitochondrial insensitive NAD pool 158
Poly(ADP-ribose) catabolism triggers AMP-dependent mitochondrial energy failure 157
Krebs Cycle Metabolite Profiling for Identification and Stratification of Pheochromocytomas/Paragangliomas due to Succinate Dehydrogenase Deficiency. 157
Loss of sdhb in zebrafish larvae recapitulates human paraganglioma characteristics 157
Pheochromocytoma/paraganglioma preclinical models: which to use and why? 156
The Ca2+ concentration of the endoplasmic reticulum is a key determinant of ceramide-induced apoptosis: significance for the molecular mechanism of Bcl-2 action. 156
Analysis of telomere maintenance related genes reveals NOP10 as a new metastatic-risk marker in pheochromocytoma/paraganglioma 153
Distal vagina smooth muscle contractility mechanisms: effects of in vivo sex steroids treatment in an animal experimental model of ovariectomy 148
Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomas 148
Recombinant expression of the voltage-dependent anion channel enhances the transfer of Ca2+ microdomains to mitochondria. 148
Tumor necrosis factor-α exerts promyogenic action in C2C12 myoblasts via sphingosine kinase/S1P2 signaling. 147
SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: A multicenter interobserver variation analysis using virtual microscopy: A Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T) 146
INHIBITION OF POLY(ADP-RIBOSE) GLYCOHYDROLASE BY GALLOTANNIN SELECTIVELY UP-REGULATES EXPRESSION OF PRO-INFLAMMATORY GENES. 144
Primary fibroblast co-culture stimulates growth and metabolism in Sdhb-impaired mouse pheochromocytoma MTT cells 144
Sphingosine 1-phosphate inhibits cell migration in C2C12 myoblasts 139
Sphingosine 1-phosphate differentially regulates proliferation of C2C12 reserve cells and myoblasts 136
Anti-ribosomal P protein antibodies detected by immunoblotting in patients with connective tissue diseases: their specificity for SLE and association with IgG anticardiolipin antibodies. 136
Human satellite cell proliferation in vitro is regulated by autocrine secretion of IL-6 stimulated by a soluble factor(s) released by activated monocytes. 133
Sphingosine 1-phosphate receptors modulate intracellular Ca2+ homeostasis 133
A role for calcium in Bcl-2 action? 129
Potential pitfalls of SDH immunohistochemical detection in paragangliomas and phaeochromocytomas harbouring germline SDHx gene mutation 128
Pitfalls in Genetic Analysis of Pheochromocytomas/Paragangliomas-Case Report. 126
Recombinant aequorin and green fluorescent protein as valuable tools in the study of cell signalling. 124
MAML3-fusions modulate vascular and immune tumour microenvironment and confer high metastatic risk in pheochromocytoma and paraganglioma 123
Sphingosine 1-phosphate increases glucose uptake through trans-activation of insulin receptor. 123
Regulation of epinephrine biosynthesis in HRAS-mutant paragangliomas 122
Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis. 118
Malignant Pheochromocytoma 116
Role of MDH2 pathogenic variant in pheochromocytoma and paraganglioma patients 116
Metabolomics, machine learning and immunohistochemistry to predict succinate dehydrogenase mutational status in phaeochromocytomas and paragangliomas 111
Nuclear poly(ADP-ribose) polymerase-1 rapidly triggers mitochondrial dysfunction. 110
TGFbeta protects mesoangioblasts from apoptosis via sphingosine kinase-1 regulation. 110
Pros and cons of surgical versus conservative management for head and neck paraganglioma: a real-world data analysis 107
Outcome of fifty-five newborns of antiphospholipid antibody-positive mothers treated with calcium heparin during pregnancy. 90
Preclinic and Translational Research in Adrenal Malignancies 76
Presurgical Succinate MetAstatic Risk Tool (P-SMART) in Paragangliomas 48
Hypogonadism and sexual function in men affected by adrenocortical carcinoma under mitotane therapy. 23
Galectin-3 inhibitor selvigaltin dosed therapeutically in vivo in a rabbit model of metabolic syndrome induced by high-fat diet: effects on rabbit differentiated adipocytes 7
Totale 13.114
Categoria #
all - tutte 37.665
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.665


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022465 0 47 57 16 17 27 18 47 11 30 70 125
2022/20231.196 96 280 54 73 74 185 148 49 134 26 45 32
2023/2024577 14 54 76 36 45 66 19 135 30 42 44 16
2024/20253.504 104 368 217 586 896 431 112 272 88 99 161 170
2025/20264.591 489 649 436 376 505 166 531 220 263 257 143 556
2026/2027283 181 102 0 0 0 0 0 0 0 0 0 0
Totale 13.114